CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-05 | Lundberg Sven Ante Director | Grant or award · Stock Option (right to buy) | +16,900 | 16,900 | ||
| 2021-02-05 | Lubner David Charles Director | Grant or award · Stock Option (right to buy) | +16,900 | 16,900 | ||
| 2021-02-05 | Beckman Daniella Director | Grant or award · Stock Option (right to buy) | +16,900 | 16,900 | ||
| 2021-02-05 | ANG ROBERT President and CEO | Grant or award · Employee Stock Option (right to buy) | +51,060 | 51,060 |
Page 18 of 18 · 344 trades